Big Med-Tech Firms Train Device Regulators In Emerging Markets
This article was originally published in The Gray Sheet
Executive SummaryThe largest multinational medical device companies are making an effort not only to lobby governments in emerging foreign markets to influence regulations, but to actually train the regulators on what industry sees as best practices
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?